Results 11 to 20 of about 8,677 (217)

Differentiating Branch Duct and Mixed IPMN in Endoscopically Collected Pancreatic Cyst Fluid via Cytokine Analysis [PDF]

Gastroenterology Research and Practice, 2012
Background. Differentiating branch duct from mixed intraductal papillary mucinous neoplasm (BD-IPMN) is problematic, but clinically important as mixed IPMNs are managed surgically, while some BD-IPMN may be followed. Inflammatory mediator proteins (IMPs)
Linda S. Lee, Andrew M. Bellizzi, Peter A. Banks, Nisha I. Sainani, Vivek Kadiyala, Shadeah Suleiman, Darwin L. Conwell, Joao A. Paulo   +7 more
doaj   +2 more sources

Branch Duct IPMN-Associated Acute Pancreatitis in a Large Single-Center Cohort Study

Diagnostics
Background/Objectives: IPMNs are a possible cause of acute pancreatitis (AP). IPMN-associated-AP is considered a relative indication for surgery for the prevention of recurrent attacks of pancreatitis and for a hypothesized increased cancer risk.
Nicolò de Pretis, Luigi Martinelli, Antonio Amodio, Federico Caldart, Salvatore Crucillà, Maria Sole Battan, Alberto Zorzi, Stefano Francesco Crinò, Maria Cristina Conti Bellocchi, Laura Bernardoni, Giulia De Marchi, Pietro Campagnola, Roberto Salvia, Armando Gabbrielli, Alessandro Marcon, Luca Frulloni   +15 more
doaj   +2 more sources

Intraductal Papillary Mucinous Neoplasms (IPMN): Diagnosis, Classification, and Risk Assessment - A Review of Current Medical Knowledge [PDF]

Journal of Education, Health and Sport
Introduction In recent years, the widespread utilisation of advanced imaging modalities has led to a surge in the detection rate of pancreatic cystic lesions, particularly intraductal papillary mucinous neoplasms (IPMN).
Karina Otręba, Joanna Cieszkowska, Karolina Czupryńska, Piotr Daniel, Michał Leśkiewicz, Justyna Składanek   +5 more
doaj   +2 more sources

A retrospective study of intraductal papillary neoplasia of the pancreas (IPMN) under surveillance [PDF]

, 2022
Background and objective: The growing number of identified intraductal papillary mucinous neoplasm (IPMN) patients places greater pressure on healthcare systems. Only a minority of patients have IPMN-related symptoms.
Seppänen, Hanna, Kaprio, Tuomas, Nieminen, Heini, Johansson, Katarina, Lantto, Eila, Haglund, Caj, Lehtimäki, Tiina E., Katarina Johansson, Eila Lantto, Tuomas Kaprio, Tiina E. Lehtimäki, Caj Haglund, Hanna Seppänen, Heini Nieminen   +13 more
core   +1 more source

The molecular, immune features, and risk score construction of intraductal papillary mucinous neoplasm patients

Frontiers in Molecular Biosciences, 2022
Intraductal papillary mucinous neoplasm (IPMN) is a common pancreatic precancerous lesion, with increasing incidence in recent years. However, the mechanisms of IPMN progression into invasive cancer remain unclear.
Xing Huang, Yipeng Feng, Yipeng Feng, Yipeng Feng, Dawei Ma, Hanlin Ding, Hanlin Ding, Hanlin Ding, Gaochao Dong, Gaochao Dong, Yan Chen, Xiaochen Huang, Jingyuan Zhang, Xinyu Xu, Chen Chen   +14 more
doaj   +1 more source

Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms

Clinical Epigenetics, 2023
Background Intraductal papillary mucinous neoplasms (IPMNs), a type of cystic pancreatic cancer (PC) precursors, are increasingly identified on cross-sectional imaging and present a significant diagnostic challenge.
Ankit Chhoda, Anup Sharma, Bethsebie Sailo, Haoyu Tang, Nensi Ruzgar, Wan Ying Tan, Lee Ying, Rishabh Khatri, Anand Narayanan, Shrikant Mane, Bony De Kumar, Laura D. Wood, Christine Iacobuzio-Donahue, Christopher L. Wolfgang, John W. Kunstman, Ronald R. Salem, James J. Farrell, Nita Ahuja   +17 more
doaj   +1 more source

Isolation of pancreatic microbiota from cystic precursors of pancreatic cancer with intracellular growth and DNA damaging properties

Gut Microbes, 2021
Emerging research suggests gut microbiome may play a role in pancreatic cancer initiation and progression, but cultivation of the cancer microbiome remains challenging.
Asif Halimi, Giorgio Gabarrini, Michał Jacek Sobkowiak, Zeeshan Ateeb, Haleh Davanian, Rogier Aäron Gaiser, Urban Arnelo, Roberto Valente, Alicia Y.W. Wong, Carlos Fernández Moro, Marco Del Chiaro, Volkan Özenci, Margaret Sällberg Chen   +12 more
doaj   +1 more source

Intraductal papillary mucinous neoplasm (IPMN) of the pancreas that recurred as a ductal adenocarcinoma likely via intraductal spread: A case report and review of the literature

Human Pathology Reports, 2023
It is hypothesized that cells of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas can move through the pancreatic duct and seed to form a new tumor (intraductal spread).
Hisashi Tamada, Yasuko Fujita, Kazuhiro Toriyama, Masataka Haneda, Seiji Natsume, Nozomi Okuno, Waki Hosoda   +6 more
doaj   +1 more source

Endoscopic pancreatic sphincterotomy in patients with IPMN-related recurrent pancreatitis: A single center experience

, 2023
Acute recurrent pancreatitis (ARP) is a rare manifestation of Intraductal Papillary Mucinous Neoplasms (IPMN) of the pancreas; ARP is a relative indication for pancreatic surgery in the setting of IPMN. Endoscopic pancreatic sphincterotomy (EPS) has been
Schepis, T, Nista, E C, Familiari, P, Boškoski, I, Perri, V, Costamagna, G, Tringali, A   +6 more
core   +1 more source

Pancreatico-gastric fistula arising from IPMN associated with ductal adenocarcinoma of the pancreas: a case report and a literature review

Frontiers in Surgery, 2023
IntroductionAn intraductal papillary mucinous neoplasm (IPMN) is a potentially malignant cystic tumor that is characterized by an excessive papillary proliferation of mucin-producing epithelial cells.
M. AbuDalu, Y. Munz, G. Ohana
doaj   +1 more source